A Multicenter, Double-blind, Placebo-controlled, Randomized, Parallel-group Study to Evaluate the Efficacy of Oral AB1010 in Adults Patients With Mild to Moderate Alzheimer-type Disease
Latest Information Update: 09 Nov 2021
At a glance
- Drugs Masitinib (Primary)
- Indications Alzheimer's disease
- Focus Proof of concept; Therapeutic Use
- 20 May 2013 35 patients were enrolled, according to an AB Science media release.
- 15 Sep 2009 New trial record